EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin‐18 isoform 2 splicing variants in gastric cancer and other solid tumours

Masuko Katoh, Izuma Nakayama, Zev A Wainberg iD, Kohei Shitara iD, Masaru Katoh iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1736 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Masuko Katoh und 4 weiteren Autor:innen. Beteiligte Einrichtung: M & M Precision Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Claudins, Antibodies, Monoclonal, Receptor, Fibroblast Growth Factor, Type 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grants-in-aid for Knowledge-Base and the Global Network Projects..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsClaudinsAntibodies, MonoclonalReceptor, Fibroblast Growth Factor, Type 2HumansProtein IsoformsNeoplasms

Substanzen

ClaudinsAntibodies, MonoclonalReceptor, Fibroblast Growth Factor, Type 2CLDN18 protein, humanProtein IsoformsFGFR2 protein, human

Autor:innen und Institutionen

  • M & M Precision Medicine, Tokyo, Japan.
  • Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Department of Medicine, University of California Los Angeles, Los Angeles, California, USA.
  • Department of Omics Network, National Cancer Center, Tokyo, Japan.

ORCID-Profile: Zev A Wainberg, Kohei Shitara, Masaru Katoh

Förderung

  • Grants-in-aid for Knowledge-Base and the Global Network Projects.

Zitieren

APA

Katoh, M., Nakayama, I., Wainberg, Z. A., Shitara, K., & Katoh, M. (2024). Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin‐18 isoform 2 splicing variants in gastric cancer and other solid tumours. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1736

Vancouver

Katoh M, Nakayama I, Wainberg ZA, Shitara K, Katoh M. Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin‐18 isoform 2 splicing variants in gastric cancer and other solid tumours. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1736

BibTeX
@article{Katoh2024,
  author = {Katoh, Masuko and Nakayama, Izuma and Wainberg, Zev A and Shitara, Kohei and Katoh, Masaru},
  title = {Monoclonal antibodies that target fibroblast growth factor receptor 2 isoform b and Claudin‐18 isoform 2 splicing variants in gastric cancer and other solid tumours},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1736}
}
Kostenlos starten →